Publications by Professor Chris Day - ePrints

Browsing publications by Professor Chris Day.

Newcastle Authors	Title	Year
Dr Rebecca Darlay Professor Heather Cordell Professor Ann Daly Professor Chris Day Dr Steven Masson et al.	Corrigendum to: 'A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers' [J Hepatol 2022 (76) 275–282] (Journal of Hepatology (2022) 76(2) (275–282), (S0168827821021115), (10.1016/j.jhep.2021.10.005))	2022
Dr Olivier Govaere Dr Rebecca Darlay Dr Julien Peltier Dr Jeremy Palmer Dr Massimo Younes et al.	Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease	2022
Dr Rebecca Darlay Dr Steven Masson Professor Chris Day Professor Ann Daly Professor Heather Cordell et al.	Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors	2021
Dr Steven Masson Professor Ann Daly Professor Heather Cordell Professor Chris Day	Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers	2021
Professor Quentin Anstee Dr Rebecca Darlay Dr Simon Cockell Dr Olivier Govaere Dr Dina Tiniakos et al.	Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort	2020
Dr Timothy Hardy Kristy Wonders Dr Massimo Younes Professor Pierre Bedossa Entesar Betelmal et al.	The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease	2020
Dr Olivier Govaere Dr Simon Cockell Dr Dina Tiniakos Dr Rachel Queen Dr Massimo Younes et al.	Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis	2020
Professor Chris Day Professor Alastair Burt	Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment	2019
Dr Dave Houghton Dr Kate Hallsworth Dr Sophie Cassidy Christian Thoma Dr Leah Avery et al.	The degree of hepatic steatosis associates with impaired cardiac and autonomic function	2019
Dr Steven Masson Professor Ann Daly Professor Heather Cordell Professor Chris Day	Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis	2018
Professor Quentin Anstee Professor Chris Day Professor Arun Sanyal	Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030	2018
Dr Dave Houghton Dr Timothy Hardy Dr Christopher Stewart Linda Errington Professor Chris Day et al.	Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes	2018
Professor Stuart McPherson Dr Nina Wilson Dr Dina Tiniakos Dr Jennifer Wilkinson Professor Alastair Burt et al.	A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis	2017
Professor Stuart McPherson Dr Timothy Hardy Dr Dina Tiniakos Professor Alastair Burt Professor Chris Day et al.	Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis	2017
Dr Sally Coulthard Professor Chris Day Professor Ann Daly	Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study	2017
Dr Dave Houghton Dr Sophie Cassidy Dr Christian Thoma Dr Kate Hallsworth Dr Leah Avery et al.	Autonomic function is impaired across the spectrum of NAFLD	2017
Dr Mikolaj Ogrodnik Dr Satomi Miwa Dr Dina Tiniakos Dr Caroline Wilson Professor Chris Day et al.	Cellular senescence drives age-dependent hepatic steatosis	2017
Dr Dave Houghton Dr Kate Hallsworth Dr Christian Thoma Dr Sophie Cassidy Dr Timothy Hardy et al.	Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers	2017
Dr Dave Houghton Christian Thoma Dr Kate Hallsworth Dr Sophie Cassidy Dr Timothy Hardy et al.	Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial	2017
Dr Timothy Hardy Dr Mujdat Zeybel Professor Chris Day Dr Christian Dipper Dr Steven Masson et al.	Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease	2017
Professor Quentin Anstee Dr Yang-Lin Liu Dr Rebecca Darlay Professor Heather Cordell Professor Ann Daly et al.	Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans	2017
Dr Dina Tiniakos Professor Quentin Anstee Professor Chris Day Professor Alastair Burt Dr John Brain et al.	Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference	2016
Dr Dave Houghton Dr Sophie Cassidy Dr Kate Hallsworth Dr Kieren Hollingsworth Professor Roy Taylor et al.	Exercise reduces liver fat and improves body composition but not insulin sensitivity or inflammatory markers in non-alcoholic steatohepatitis	2016
Professor Quentin Anstee Professor Chris Day	Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease	2016
Dr Dave Houghton Professor Chris Day Professor Mike Trenell	Gut microbiota and lifestyle interventions in NAFLD	2016
Professor Helen Reeves Marco Zaki Professor Chris Day	Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD	2016
Dr Nimantha de Alwis Professor Quentin Anstee Professor Chris Day	How to Diagnose Nonalcoholic Fatty Liver Disease	2016
Dr Timothy Hardy Professor Fiona Oakley Professor Quentin Anstee Professor Chris Day	Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum	2016
Professor Chris Day	Physical activity is prospectively associated with adolescent nonalcoholic fatty liver disease	2016
Professor Ann Daly Professor Chris Day	Variants in the LGALS9 Gene Are Associated With Development of Liver Disease in Heavy Consumers of Alcohol	2016
Professor Chris Day Dr Steven Masson Professor Ann Daly Professor Heather Cordell	Brief Report: Genetics of Alcoholic Cirrhosis-GenomALC Multinational Study	2015
Dr Sophie Cassidy Dr Kate Hallsworth Dr Christian Thoma Dr Guy MacGowan Dr Kieren Hollingsworth et al.	Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control	2015
Professor Chris Day	Childhood Energy Intake Is Associated with Nonalcoholic Fatty Liver Disease in Adolescents	2015
Anna Whitehead Dr Gillian Patman Professor Chris Day Dr Dina Tiniakos Professor Quentin Anstee et al.	Effects of FXR agonist PX20606 on tumour formation in animal models of non-alcoholic fatty liver disease	2015
Professor Stuart McPherson Dr Timothy Hardy Elsbeth Henderson Professor Alastair Burt Professor Chris Day et al.	Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management	2015
Dr Dave Houghton Dr Christian Thoma Dr Kate Hallsworth Dr Kieren Hollingsworth Professor Chris Day et al.	Exercise reduces liver fat, visceral fat and circulating triglycerides, but not circulating inflammatory markers in non-alcoholic steatohepatitis	2015
Professor Quentin Anstee Professor Ann Daly Professor Chris Day	Genetics of Alcoholic Liver Disease	2015
Dr Sophie Cassidy Christian Thoma Dr Kate Hallsworth Dr Jehill Parikh Dr Kieren Hollingsworth et al.	High intensity intermittent training improves cardiac function and reduces liver fat in adults with Type 2 diabetes: an MRI/S study	2015
Professor Stuart McPherson Dr Timothy Hardy Professor Alastair Burt Professor Chris Day Professor Quentin Anstee et al.	High rate of false positives for advanced fibrosis when simple non-invasive fibrosis tests are used in older patients (>=65 years) with NAFLD	2015
Dr Jeremy Palmer Dr Yang-Lin Liu Professor Chris Day Professor Ann Daly Professor Quentin Anstee et al.	Mechanistic Study of TM6SF2 in NAFLD pathogenesis: Stably transfected Huh7 cells over-expressing the TM6SF2 E167K variant exhibit greater levels of oxidative stress	2015
Dr Kate Hallsworth Christian Thoma Dr Kieren Hollingsworth Dr Sophie Cassidy Professor Quentin Anstee et al.	Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: A randomised controlled trial	2015
Professor Chris Day	Nonalcoholic fatty liver disease	2015
Professor Chris Day Professor Quentin Anstee	Nonalcoholic Fatty Liver Disease: Foreword	2015
Dr Timothy Hardy Professor Quentin Anstee Professor Chris Day	Nonalcoholic fatty liver disease: new treatments	2015
Dr Sarah Wiscombe Emerita Professor Julia Newton Professor Chris Day Emeritus Professor John Gibson Dr Sophie West et al.	Obstructive sleep apnoea is common in adults with biopsy-proven non-alcoholic fatty liver disease	2015
Professor Ann Daly Professor Chris Day	PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease	2015
Professor Chris Day Dr Steven Masson	Prednisolone or Pentoxifylline for Alcoholic Hepatitis	2015
Professor Quentin Anstee Dr Yang-Lin Liu Professor Chris Day Professor Helen Reeves	Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance	2015
Professor Chris Day Professor Pierre Bedossa	Substantial variability of the diagnostic accuracy of serum fibrosis markers across multiple cohorts of nash patients in various centers : the case for the negative predictive value	2015
Professor Chris Day	The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: Findings from a cross-sectional study	2015
Michelle Thursby Professor Chris Day Ellen Allison Dr Steven Masson Professor Luke Vale et al.	The clinical effectiveness and cost-effectiveness of STeroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2x2 factorial, randomised controlled trial.	2015
Rodolphe Anty Professor Chris Day Professor Ann Daly Anh Tran Professor Quentin Anstee et al.	The FNDC5 rs3480 is protective on the steatosis and fibrosis in patients with NAFLD	2015
Professor Quentin Anstee Professor Chris Day	The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2	2015
Professor Ann Daly Professor Chris Day Dr Yang-Lin Liu Professor Quentin Anstee	TM6SF2 as a Genetic Risk Factor for Fibrosis	2015
Dr Yang-Lin Liu Professor Ann Daly Professor Chris Day Professor Quentin Anstee	TM6SF2: Catch-22 in the Fight Against Nonalcoholic Fatty Liver Disease and Cardiovascular Disease?	2015
Professor Quentin Anstee Professor Chris Day	Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis	2015
Ching Ng Dr Abul Hasnat Professor Chris Day Professor Ann Daly	N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group	2014
Dr Yang-Lin Liu Dr Gillian Patman Julian Leathart Professor Alastair Burt Professor Chris Day et al.	Carriage of the PNPLA3 rs738409 C>G Polymorphism Confers an Increased Risk of Non-Alcoholic Fatty Liver Disease Associated Hepatocellular Carcinoma	2014
Dr Steven Masson Ingrid Emmerson Elsbeth Henderson Dr Emma Fletcher Professor Alastair Burt et al.	Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease	2014
Julian Leathart Professor Ann Daly Professor Chris Day Professor Quentin Anstee	Gene Polymorphisms of Cellular Senescence Marker P21 and Disease Progression in Non-Alcohol-Related Fatty Liver Disease	2014
Professor Chris Day	Lack of Efficacy of an Inhibitor of PDE4 in Phase 1 and 2 Trials of Patients With Nonalcoholic Steatohepatitis	2014
Professor Stuart McPherson Elsbeth Henderson Dr Timothy Hardy Professor Alastair Burt Professor Chris Day et al.	Natural history of NAFLD: A study of 108 patients with paired liver biopsies	2014
Professor Stuart McPherson Dr Timothy Hardy Professor Alastair Burt Professor Chris Day Professor Quentin Anstee et al.	Natural History of NAFLD: A Study of 108 Patients with Paired Liver Biopsies	2014
Dr Kate Hallsworth Dr Christian Thoma Sarah Moore Dr Thomas Ploetz Professor Quentin Anstee et al.	Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls	2014
Beth Anderson Professor Chris Day	Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: A cross- Sectional study of 1874 general population adolescents	2014
Dr James Frith Professor Fai Ng Professor Chris Day Dr Brendan Payne Professor Neil Sheerin et al.	Orthostatic intolerance is common in chronic disease - A clinical cohort study	2014
Professor Chris Day	Serum Ferritin Levels Lack Diagnostic Accuracy for Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease	2014
Professor Stuart McPherson Elsbeth Henderson Professor Alastair Burt Professor Chris Day Professor Quentin Anstee et al.	Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease	2014
Professor Chris Day Dr Steven Masson	Steroids or Pentoxifylline for Alcoholic Hepatitis: Results of the STOPAH Trial	2014
Dr Yang-Lin Liu Professor Helen Reeves Professor Alastair Burt Dr Dina Tiniakos Professor Stuart McPherson et al.	TM6SF2 rs58542926 Influences Hepatic Fibrosis Progression in Patients with Non-Alcoholic Fatty Liver Disease	2014
Dr Jess Dyson Professor Chris Day	Treatment of Non-Alcoholic Fatty Liver Disease	2014
Professor Chris Day	Weight trajectories through infancy and childhood and the risk of non-alcoholic fatty liver disease in adolescence: The ALSPAC study	2014
Professor Quentin Anstee Dr Rebecca Darlay Julian Leathart Yilei Liu Professor Alastair Burt et al.	A candidate-gene approach to validation of genetic modifier associations using a large cohort with histologically characterised non-alcoholic fatty liver disease	2013
Professor Chris Day	A Large Independent Validation Study of Nonivasive Scores to Predict Advanced Fibrosis in NAFLD	2013
Anna Whitehead Dr Gillian Patman Liam Cornell Dr Despina Televantou Professor Nicola Curtin et al.	A Role for DNA Repair Protein Kinase (DNA-PK) in the Progression of Simple Steatosis to Steatohepatitis (NASH)?	2013
Professor Stuart McPherson Professor Quentin Anstee Professor Chris Day Professor Alastair Burt	Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?	2013
Dr Kate Hallsworth Dr Kieren Hollingsworth Dr Christian Thoma Professor Djordje Jakovljevic Dr Guy MacGowan et al.	Cardiac function improves following high intensity intermittent exercise in adults with non-alcoholic fatty liver disease	2013
Dr Kate Hallsworth Dr Kieren Hollingsworth Dr Christian Thoma Professor Djordje Jakovljevic Dr Guy MacGowan et al.	Cardiac function improves following high intensity intermittent exercise in adults with non-alcoholic fatty liver disease	2013
Dr Kate Hallsworth Dr Kieren Hollingsworth Dr Christian Thoma Professor Quentin Anstee Professor Chris Day et al.	Cardiac Function Improves Following High Intensity Intermittent Exercise Therapy in Non-Alcoholic Fatty Liver Disease	2013
Dr Kate Hallsworth Dr Kieren Hollingsworth Dr Christian Thoma Professor Djordje Jakovljevic Dr Guy MacGowan et al.	Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease	2013
Dr Yang-Lin LIU Dr Gillian Patman Julian Leathart Professor Alastair Burt Professor Chris Day et al.	Carriage of PNPLA3 I148M is Associated with an Increased Risk of Non-Alcoholic Fatty Liver Disease Associated Hepatocellular Carcinoma	2013
Professor Chris Day	From NAFLD in clinical practice to answers from guidelines	2013
Chris Elliott Dr James Frith Professor Chris Day Professor David Jones Emerita Professor Julia Newton et al.	Functional Impairment in Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease Is Significant and Persists over 3 Years of Follow-Up	2013
Professor Ann Daly Professor Chris Day	Genetic Polymorphisms of Galectin-9 (Gal-9) Associated with Risk of Developing Alcoholic Liver Disease (ALD) in Humans	2013
Dr Luca Miele Professor Chris Day	Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target	2013
Dr Kate Hallsworth Dr Christian Thoma Professor Quentin Anstee Professor Chris Day Professor Mike Trenell et al.	Higher Objectively Measured Sedentary Behaviour and Lower Levels of Physical Activity than Matched Healthy Controls	2013
Dr Christian Thoma Dr Kate Hallsworth Dr Kieren Hollingsworth Professor Quentin Anstee Professor Chris Day et al.	HIGH-INTENSITY INTERMITTENT EXERCISE THERAPY REDUCES LIVER FAT AND IMPROVES BODY COMPOSITION IN ADULTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE	2013
Professor Chris Day Professor Mark Walker Professor Helen Reeves	Krüppel Like Factor 6 (KLF6) Protects From NAFLD Progression through Regulation of Adipose Tissue Insulin Resistance	2013
Professor Quentin Anstee Dr Yang-Lin Liu Professor Heather Cordell Dr Rebecca Darlay Professor Chris Day et al.	Mapping Expression Quantitative Traits Loci (EQTL) for PNPLA3 Gene Identifies Additional SNPs Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) Independent of rs738409	2013
Dr Gillian Patman Dr Despina Televantou Anna Whitehead Professor Chris Day Professor Fiona Oakley et al.	Mild Steatosis and Impaired Glucose Tolerance are Associated with Liver Cancer Development, While Progression to Nash Increases Number/Size in an Animal Model of NAFLD	2013
Dr Stuart Kendrick Professor Chris Day	Natural history and factors influencing the course of alcohol-related liver disease	2013
Professor Quentin Anstee Professor Chris Day	Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis	2013
Professor Djordje Jakovljevic Dr Kate Hallsworth Christian Thoma Professor Chris Day Emerita Professor Julia Newton et al.	Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease	2013
Professor Chris Day	Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease	2013
Professor Chris Day Dr Steven Masson	Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial	2013
Dr Gillian Patman Dr Despina Televantou Anna Whitehead Professor Chris Day Professor Alastair Burt et al.	Sulfatase-2 (SULF2) Expressed in Hepatocytes and Stromal Cells Contributes to the Development of Steatosis, the Progression of NAFLD to Fibrosis and the Advancement of Cancer	2013
Professor Quentin Anstee Professor Chris Day	The genetics of NAFLD	2013
Dr Christian Thoma Dr Kate Hallsworth Dr Kieren Hollingsworth Professor Roy Taylor Professor Chris Day et al.	Unsupervised high-intensity intermittent training reduces liver fat and improves body composition in adults with non-alcoholic fatty liver disease (NAFLD)	2013
Professor Alastair Burt Professor Chris Day	Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease	2013
Dr Timothy Hardy Dr Christopher Wells Dr Stuart Kendrick Professor Chris Day Professor Alastair Burt et al.	White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers	2013
Professor Quentin Anstee Professor Chris Day	S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility	2012
Professor Quentin Anstee Professor Chris Day	A lipid to treat non-alcoholic fatty liver disease – The dawn of ‘lipo-rehabilitation’?	2012
Professor Alastair Burt Professor Chris Day	An algorithm combining direct and indirect liver fibrosis tests enhances diagnostic performance for the detection of advanced fibrosis (F3-4) in NAFLD minimising the need for liver biopsy	2012
Dr Kate Hallsworth Dr Kieren Hollingsworth Dr Christian Thoma Professor Roy Taylor Professor Chris Day et al.	Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease	2012
Dr Kate Hallsworth Dr Kieren Hollingsworth Dr Christian Thoma Professor Roy Taylor Professor Chris Day et al.	Cardiac structure and function is altered in adults with non-alcoholic fatty liver disease	2012
Dr Steven Masson Ingrid Emmerson Professor Alastair Burt Professor Chris Day Dr Stephen Stewart et al.	Clinical but not histological factors predict long-term prognosis in patients with biopsy proven advanced alcoholic liver disease	2012
Professor Chris Day	Clinical Spectrum and Therapy of Non-Alcoholic Steatohepatitis	2012
Dr James Frith Professor David Jones Professor Chris Day Emerita Professor Julia Newton	Cognitive impairment in non-cirrhotic chronic liver disease is unrelated to liver disease severity but associated with ineffective baroreflex function	2012
Dr James Frith Sandra Kerr Dr Lisa Robinson Chris Elliott Katharine Wilton et al.	Falls and Fall-Related Injury Are Common in Older People with Chronic Liver Disease	2012
Professor Ann Daly Professor Chris Day	Genetic association studies in drug-induced liver injury	2012
Professor Quentin Anstee Dr Rebecca Darlay Julian Leathart Professor Helen Reeves Professor Alastair Burt et al.	Genome-Wide Association Analysis Confirms Importance of PNPLA3 and Identifies Novel Variants Associated With Histologically Progressive Steatohepatitis in NAFLD	2012
Dr Gillian Patman Laura Pascoe Dr Luca Miele Douglas Hui Professor Alastair Burt et al.	Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease	2012
Professor Chris Day	Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis	2012
Dr Christian Thoma Professor Chris Day Professor Mike Trenell	Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review	2012
Dr Kate Hallsworth Dr Christian Thoma Sarah Moore Professor Roy Taylor Professor Chris Day et al.	Physical activity levels are lower in people with non-alcoholic fatty liver disease than matched healthy controls	2012
Ahmad Alserri Professor Quentin Anstee Julian Leathart Julia Patch Professor Chris Day et al.	The SOD2 C₄₇T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies	2012
Professor Stuart McPherson Dr Timothy Hardy Professor Alastair Burt Professor Chris Day Professor Quentin Anstee et al.	The FIB-4 score reliability excludes advanced fibrosis in a diabetic cohort with NAFLD	2012
Dr Stefano Ballestri Professor Chris Day	Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD	2012
Professor Ann Daly Professor Chris Day	A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease	2011
Professor Stuart McPherson Professor Quentin Anstee Elsbeth Henderson Professor Alastair Burt Professor Chris Day et al.	Are simple non-invasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?	2011
Professor Ann Daly Dr Stefano Ballestri Professor Chris Day	Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease	2011
Professor Quentin Anstee Professor Ann Daly Professor Chris Day	Genetic modifiers of non-alcoholic fatty liver disease progression	2011
Professor Quentin Anstee Professor Ann Daly Professor Chris Day	Genetics of alcoholic liver disease and nonalcoholic fatty liver disease	2011
Professor Quentin Anstee Professor Stuart McPherson Professor Chris Day	How big a problem is non-alcoholic fatty liver disease?	2011
Professor Chris Day	Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Incident Cardiovascular Disease	2011
Dr Nimantha De Alwis Julian Leathart Professor Gavin Hudson Dr Angela Pyle Dr Catherine Mowbray et al.	Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease	2011
Professor Chris Day	Non-alcoholic fatty liver disease: a massive problem	2011
Professor Chris Day	Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances	2011
Dr Stefano Ballestri Professor Chris Day Professor Ann Daly	Polymorphism in the Farnesyl Diphosphate Farnesyl Transferase 1 Gene and Nonalcoholic Fatty Liver Disease Severity	2011
Professor Alastair Burt Alison Bray Professor Chris Day	Recombinant lysosomal acid lipase normalizes liver weight, transaminases and histopathological abnormalities in an in vivo model of cholesteryl ester storage disease	2011
Dr Kate Hallsworth Dr Gulnar Fattakhova Dr Kieren Hollingsworth Dr Christian Thoma Sarah Moore et al.	Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease	2011
Dr Kate Hallsworth Dr Gulnar Fattakhova Dr Kieren Hollingsworth Christian Thoma Sarah Moore et al.	Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease	2011
Dr Kate Hallsworth Dr Gulnar Fattakhova Dr Kieren Hollingsworth Dr Christian Thoma Sarah Moore et al.	Resistance exercise improves liver lipid, fat oxidation and glucose control in adults with non-alchoholic fatty liver disease independent of weight loss	2011
Dr Kate Hallsworth Dr Kieren Hollingsworth Dr Christian Thoma Sarah Moore Professor Roy Taylor et al.	Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss	2011
Professor Chris Day	Risk of all-cause and cardiovascular mortality in patients with chronic liver disease	2011
Professor Chris Day Dr Peter Donaldson Professor Ann Daly	Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and class II alleles	2011
Dr Eileen Lee Professor Chris Day	The Natural History of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis or Cirrhosis: An International Collaborative Study	2011
Julian Leathart Professor Ann Daly Professor Chris Day	The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver	2011
Professor Alastair Burt Professor Chris Day	Validation of a novel biomarker model for the prediction of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease	2011
Professor Chris Day	Vascular adhesion protein-1 promotes progression of steatohepatitis by expansion of the intrahepatic CD4+AND NKT cell populations and induction of fibrogenesis	2011
Professor Stuart McPherson Alison Burt Professor Chris Day	A comparison of non-invasive fibrosis scoring systems in patients with non-alcoholic fatty liver disease	2010
Elise Andrews Professor Matthew Wright Professor Chris Day Professor Ann Daly	A Role for the Pregnane X Receptor in Flucloxacillin-Induced Liver Injury	2010
Dr Stuart Kendrick Dr Graeme O'Boyle Professor Jelena Mann Dr Mujdat Zeybel Dr Jeremy Palmer et al.	Acetate, the Key Modulator of Inflammatory Responses in Acute Alcoholic Hepatitis	2010
Dr Jeremy Palmer Dr Imran Patanwala Elsbeth Henderson Professor Chris Day Professor David Jones et al.	Allo- and auto-antibody responses in ALD as biomarkers of prognosis	2010
Dr Stuart Kendrick Professor Chris Day	Can pentoxifylline secure its place in liver therapeutics?	2010
Professor Chris Day	Comparison of the Glasgow Alcoholic Hepatitis Score and the ABIC Score for the Assessment of Alcoholic Hepatitis	2010
Dr Nimantha De Alwis Professor Chris Day	Current and Future Therapeutic Strategies in NAFLD	2010
Professor Chris Day	Disorders of Coagulation and Hemostasis in Abdominal Obesity: Emerging Role of Fatty Liver	2010
Professor Alastair Burt Professor Chris Day	Elevated endotoxin levels in non-alcoholic fatty liver disease	2010
Professor Chris Day	Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease	2010
Professor Chris Day	Genetic and environmental susceptibility to non-alcoholic fatty liver disease	2010
Professor Chris Day	Genetic and Environmental Susceptibility to Non-Alcoholic Fatty Liver Disease	2010
Professor Ann Daly Julian Leathart Professor Alastair Burt Professor Chris Day	Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease	2010
Ahmad Alserri Professor Ann Daly Professor Chris Day	Homozygosity for the Patatin-Like Phospholipase-3/Adiponutrin I148M Polymorphism Influences Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease	2010
Dr Peter Donaldson Professor Ann Daly Jill Henderson Professor Chris Day	Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury	2010
Professor Ann Daly Professor Chris Day	Patatin-like phospholipase domain containing 3: A case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease	2010
Joanna Stewart Professor Rita Horvath Professor Chris Day Professor Patrick Chinnery	Polymerase γ Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity	2010
Dr James Frith Professor Chris Day Chris Elliott Professor David Jones Emerita Professor Julia Newton et al.	Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease	2010
Professor Chris Day	Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease	2010
Professor Stuart McPherson Professor Alastair Burt Professor Chris Day	Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease	2010
Professor Chris Day	Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop	2010
Professor Chris Day	Susceptibility to ALD: Where are we?	2010
Professor David Jones Professor Chris Day	The significance of autoantibodies in non-alcoholic fatty liver disease	2010
Dr Stuart Kendrick Elsbeth Henderson Dr Jeremy Palmer Professor David Jones Professor Chris Day et al.	Theophylline improves steroid sensitivity in acute alcoholic hepatitis	2010
Professor Ann Daly Dr Peter Donaldson Dr Pallav Bhatnagar Julia Patch Professor Heather Cordell et al.	HLA-B5701* genotype is a major determinant of drug-induced liver injury due to flucloxacillin	2009
Dr Nimantha De Alwis Emeritus Professor Doug Turnbull Professor Robert Taylor Dr Laura Greaves Professor Patrick Chinnery et al.	A Methodological Approach to Tracing Cell Lineage in Human Epithelial Tissues	2009
Dr Joseph Gray Dr Dipanker Chattopadhyay Dr Gary Beale Dr Gillian Patman Dr Luca Miele et al.	A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease	2009
Professor Chris Day	Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome	2009
Emerita Professor Julia Newton Professor Chris Day	Authors' response	2009
Professor Chris Day	Childhood NAFLD: A ticking timebomb?	2009
Emerita Professor Julia Newton Jessie Pairman Katharine Wilton Professor David Jones Professor Chris Day et al.	Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease	2009
Emerita Professor Julia Newton Professor Chris Day	Fatigue in non-alcoholic fatty liver disease: is there a role for hypothyroidism Response	2009
Professor Ann Daly Professor Chris Day	Genetic Association Studies in Drug-Induced Liver Injury	2009
Dr Nimantha De Alwis Professor Gavin Hudson Professor Alastair Burt Professor Chris Day Professor Patrick Chinnery et al.	Human Liver Stem Cells Originate from the Canals of Hering	2009
Dr Luca Miele Professor Chris Day	Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease	2009
Dr James Frith Professor Chris Day Elsbeth Henderson Professor Alastair Burt Emerita Professor Julia Newton et al.	Non-Alcoholic Fatty Liver Disease in Older People	2009
Dr Gary Beale Laura Pascoe Dr Luca Miele Professor Mark Walker Professor Chris Day et al.	The Kruppel-Like Factor 6 (KLF6) Genotype Which is Associated With NAFLD Progression is Associated with Higher Fasting Serum Glucose Levels in Healthy Individuals	2009
Dr Stephen Stewart Professor Chris Day Dr Eilish Gilvarry	Adverse physical effects of alcohol misuse	2008
Dr Gary Beale Dr Dipanker Chattopadhyay Dr Joseph Gray Dr Stephen Stewart Dr Mark Hudson et al.	AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease	2008
Professor Chris Day	Antioxidants plus corticosteroids in the treatment of severe acute alcoholic hepatitis: The question is still open: Reply	2008
Emerita Professor Julia Newton Professor David Jones Katharine Wilton Professor Alastair Burt Professor Chris Day et al.	Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance	2008
Dr Nimantha De Alwis Professor Chris Day	Genes and nonalcoholic fatty liver disease	2008
Dr Pallav Bhatnagar Professor Chris Day Professor Ann Daly	Genetic variants of hepatic transporters and susceptibility to drug induced liver injury	2008
Professor Chris Day	NASH predicts plasma inflammatory biomarkers independently of visceral fat in men	2008
Professor Chris Day	No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease	2008
Professor Chris Day	Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients	2008
Dr Nimantha De Alwis Professor Chris Day	Non-alcoholic fatty liver disease: The mist gradually clears	2008
Professor Chris Day	Non-alcoholic steatohepatitis: metabolic syndrome of the liver	2008
Dr Dipanker Chattopadhyay Professor Alastair Burt Professor Chris Day	Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers	2008
Elise Andrews Professor Matthew Wright Professor Chris Day Professor Ann Daly	Relevance of PXR to Flucloxacillin-induced Liver Injury	2008
Dr Luca Miele Dr Gary Beale Dr Gillian Patman Julian Leathart Professor Chris Day et al.	The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease	2008
Dr Nicholas Thompson Professor Alastair Burt Professor Chris Day Professor Helen Reeves	Warfarin induced cholestatic jaundice in a patient receiving total parenteral nutrition	2008
Dr Stuart Kendrick Professor Chris Day	A coffee with your brandy, Sir?	2007
Dr Martin Prince Professor Margaret Bassendine Dr Mark Hudson Emeritus Professor Oliver James Professor David Jones et al.	A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis	2007
Professor Chris Day	Alcohol and the liver	2007
Professor Chris Day	Benefits of lifestyle modification in NAFLD	2007
Professor Chris Day	Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C	2007
Dr Gary Beale Dr Luca Miele Professor Helen Reeves Professor Chris Day	Differential expression of GSTT1 and GSTT2 is associated with more advanced fibrosis in patients with NAFLD	2007
Dr Graeme O'Boyle Professor David Jones Professor Chris Day	Effects of ethanol on endotoxin-mediated cytokine release: Sensitisation via TLR4 but normal tolerance	2007
Dr Stuart Kendrick Dr Graeme O'Boyle Professor Jelena Mann Professor David Jones Professor Chris Day et al.	Ethanol-induced histone acetylation: A novel mechanism for enhancement of inflammation in alcoholic hepatitis?	2007
Professor Chris Day	European liver fibrosis (ELF) panel of serum markers can predict clinical outcome in a cohort of patients from England with mixed aetiology chronic liver disease	2007
Emerita Professor Julia Newton Professor David Jones Elsbeth Henderson Jessie Pairman Katharine Wilton et al.	Fatigue in NAFLD is severe and associates with excessive daytime somnolence but not with liver disease severity or insulin resistance	2007
Dr Nimantha De Alwis Professor Ann Daly Julian Leathart Dr Sushma Saksena Professor Chris Day et al.	Genetic evidence that lipid trafficking plays a key role in fibrosis in non alcoholic fatty liver disease	2007
Professor Ann Daly Julian Leathart Richard Swainsbury Professor Chris Day	Genetic Susceptibility to Diclofenac-Induced Hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 Genotypes	2007
Dr Nimantha De Alwis Professor Chris Day	Genetics of alcoholic liver disease and nonalcoholic fatty liver disease	2007
Professor Chris Day	Long-term orlistat treatment reduces endotoxinaemia in fatty liver disease patients	2007
Dr Stuart Kendrick Dr Jeremy Palmer Professor David Jones Professor Chris Day	Lymphocyte steroid sensitivity in severe alcoholic hepatitis	2007
Professor Chris Day	Management strategies in alcoholic liver disease	2007
Dr Nimantha De Alwis Dr Catherine Mowbray Dr Angela Pyle Julian Leathart Professor Patrick Chinnery et al.	Mitochondrial DNA haplogroups associated with histological severity in non-alcoholic fatty liver disease (NAFLD)	2007
Professor Chris Day	Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question	2007
Professor Chris Day	Nonsteroidal Anti-Inflammatory Drug-Induced Hepatotoxicity	2007
Professor Chris Day	Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients	2007
Professor Chris Day	Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients: Response to Schindhelm, Heine, and Diamant [3]	2007
Professor Chris Day	Recent advances in clinical practice: Benefits of lifestyle modification in NAFLD	2007
Professor Chris Day	The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids	2007
Dr Luca Miele Dr Gary Beale Julian Leathart Professor Chris Day Professor Helen Reeves et al.	The KLF6 (IVS1-27G > a) polymorphism is associated with non-progressive NAFLD	2007
Professor Ann Daly Ahmad Alserri Julian Leathart Julia Patch Professor Chris Day et al.	The mitochondrial superoxide dismutase 2 (SOD2) targeting sequence polymorphism is associated with fibrotic NAFLD: Consistent evidence from case-control and intra-familial allelic association studies	2007
Dr Sushma Saksena Professor Alastair Burt Professor Chris Day	The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD	2007
Professor Chris Day	Treatment of alcoholic liver disease	2007
Professor Chris Day	A chat on fat in the liver	2006
Alison Burt Dr Simon Harris Professor Chris Day	European liver fibrosis (ELF) markers accurately distinguish fibrosis severity in non alcoholic fatty liver disease (NAFLD); An external validation study	2006
Professor Chris Day	From fat to inflammation	2006
Professor Chris Day	Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease	2006
Professor Chris Day	Genes or environment to determine ALD and NAFLD	2006
Professor Chris Day Julian Leathart Professor Ann Daly	Genetic evidence for a role for gut flora in the pathogenesis of NASH in humans	2006
Dr Nimantha De Alwis Dr Catherine Mowbray Professor Patrick Chinnery Professor Chris Day	Mitochondrial DNA haplogrouping in non alcoholic fatty liver disease (NAFLD)	2006
Professor Chris Day	Natural history of non alcoholic steatohepatitis (NASH) cirrhosis and stage 3 fibrosis	2006
Professor Chris Day	Non-alcoholic fatty liver disease: current concepts and management strategies	2006
Professor Chris Day	Non-alcoholic fatty liver disease: Current concepts and management strategies	2006
Professor Chris Day	Non-alcoholic steatohepatitis: From cell biology to clinical practice	2006
Dr Maria Lorite Professor Alastair Burt Professor Chris Day Dr Michael Thompson	Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: Effects of platelet-derived growth factor and extracellular nucleotides	2006
Dr Kaushik Agarwal Professor Chris Day	Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation	2006
Professor Chris Day Professor Helen Reeves	The genetic basis of hepatocellular cancer	2006
Professor Chris Day	Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score	2005
Professor Chris Day	Chronic endotoxinemia in NAFLD: A potential role in the development of insulin resistance/diabetes and in liver disease progression?	2005
Dr Kaushik Agarwal Professor Chris Day	CTLA-4 gene polymorphisms are associated with acute rejection after liver transplantation	2005
Professor Chris Day	Fatty liver disease is associated with both endotoxemia and sub-clinical inflammation prior to the onset of type 2 diabetes	2005
Professor Chris Day Patrick Hayes	Grading alcoholic hepatitis	2005
Professor Chris Day	Grading alcoholic hepatitis [1] (multiple letters)	2005
Dr Sushma Saksena Professor Alastair Burt Professor Chris Day	Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis	2005
Professor Chris Day	Natural history of NAFLD: Remarkably benign in the absence of cirrhosis	2005
Professor Chris Day Emeritus Professor Steve Yeaman	Relationship between the inhibition of phosphatidic acid phosphohydrolase-1 by oleate and oleoyl-CoA ester and its apparent translocation	2005
Professor Chris Day	[abstract] Selective breast tumor growth suppression mediated by the enhanced breast cancer-specific promoter	2004
Professor Chris Day	A randomised controlled trial of calcineurin inhibitor (CNI) replacement with mycophenolate mofetil and steroids in liver transplant patients with renal dysfunction	2004
Dr Stephen Stewart Dr Beate Haugk Professor Alastair Burt Professor David Jones Professor Chris Day et al.	Anti-cytochrome P4502E1 autoantibody titre associates with immune liver histology in advanced alcoholic liver disease	2004
Dr Stephen Stewart Professor David Jones Dr Beate Haugk Professor Alastair Burt Professor Chris Day et al.	Correlation between anti-CYP2E1 titre and lymphocyte infiltration in ALD - An autoimmune disease in some patients?	2004
Professor Chris Day Professor Ann Daly	Genetic susceptibility to alcoholic liver disease	2004
Professor Chris Day	Genetic susceptibility to alcoholic liver disease	2004
Professor Ann Daly Julian Leathart Professor Chris Day	Hepatic Adducts, Circulating Antibodies, and Cytokine Polymorphisms in Patients with Diclofenac Hepatotoxicity	2004
Professor Chris Day Professor Volker Straub	Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures	2004
Dr Stephen Stewart Professor Chris Day Professor David Jones	Oxidative Stress as a Trigger for Cellular Immune Responses in Patients with Alcoholic Liver Disease	2004
Professor Chris Day	Role of oxidative stress in promoting immune reactions associated with alcoholic liver disease	2004
Professor Chris Day	Steatosis and Hepatitis C Virus: Mechanisms and Significance for Hepatic and Extrahepatic Disease	2004
Jacqui Morris Dr Stephen Stewart Professor Chris Day	The Glasgow Alcoholic Hepatitis Score identifies patients likely to benefit from corticosteroids	2004
Jacqui Morris Dr Stephen Stewart Professor Chris Day	The Glasgow Alcoholic Hepatitis Score identifies patients likely to benefit from corticosteroids	2004
Professor Chris Day	The potential role of genes in nonalcoholic fatty liver disease	2004
Professor Chris Day	Upregulation of IKK alpha/IKK beta by integrin-linked kinase is required for HER2/neu-induced NF-kappa B antiapoptotic pathway	2004
Professor Chris Day	Upregulation of IKK alpha/IKK beta by integrin-linked kinase is required for HER2/neu-induced NF-kappa B antiapoptotic pathway (vol 23, pg 3883, 2004)	2004
Dr Stephen Stewart Professor Chris Day	Validation of the Glasgow Alcoholic Hepatitis Score: Relevance to prognosis and corticosteroid response.	2004
Professor Ann Daly Julian Leathart Professor Chris Day	A "loss-of-function" polymorphism in ICAM-1 protects heavy drinkers from alcoholic liver disease	2003
Dr Anne Hicks Professor Alastair Burt Dr Michael Thompson Professor Chris Day	Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells	2003
Dr Matt Warren Professor Chris Day	Chronic pancreatitis: A treatable, common, and underdiagnosed problem in patients with ALD	2003
Professor Ann Daly Julian Leathart Dr Beate Haugk Professor David Jones Professor Alastair Burt et al.	Evidence that alcoholic liver disease is due to immune mechanisms in genetically susceptible drinkers	2003
Dr Stephen Stewart Professor Ann Daly Professor David Jones Julian Leathart Professor Chris Day et al.	Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease	2003
Dr Sushma Saksena Julian Leathart Professor Alastair Burt Emeritus Professor Oliver James Professor Ann Daly et al.	Genetic evidence supporting the two-hit model of NASH pathogenesis	2003
Dr Sushma Saksena Julian Leathart Professor Ann Daly Professor Chris Day	Manganese dependent superoxide dismutase (SOD2) targeting sequence polymorphism is associated with advanced fibrosis in patients with non-alcoholic fatty liver disease	2003
Professor Chris Day Professor David Jones	Neo-antigen specific T-cell responses are closely associated with the presence of liver disease in heavy drinkers	2003
Dr Sushma Saksena Professor Alastair Burt Professor Chris Day	Oxidative stress is an independent risk factor for the progression of non-alcoholic fatty liver disease (NAFLD) to advanced fibrosis	2003
Dr Martin Prince Emeritus Professor Oliver James Professor Chris Day Dr Mark Hudson Professor David Jones et al.	Pain as a complication of opiate antagonist therapy in cholestasis: A single centre experience	2003
Dr Martin Prince Dr Mark Hudson Professor Chris Day Emeritus Professor Oliver James Professor David Jones et al.	Pain as a complication of use of opiate antagonists for symptom control in cholestasis	2003
Julian Leathart Professor Chris Day Professor Ann Daly	Relationship of UGT2B7 genotype with diclofenac hepatotoxicity	2003
Professor Chris Day Emeritus Professor Oliver James	The effect of drinking behaviour on quality of life in patients with established alcoholic liver disease	2003
Dr Stephen Stewart Professor Chris Day	The management of alcoholic liver disease	2003
Professor Chris Day	Who gets alcoholic liver disease: Nature or nurture? (extended abstract)	2003
Julian Leathart Professor Chris Day Professor Ann Daly	Association of udp-glucuronosyltransferase (UGT) 2B7 genotype with diclofenac-induced hepatotoxicity	2002
Dr Anne Hicks Professor Alastair Burt Dr Michael Thompson Professor Chris Day	Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells	2002
Professor Chris Day	CD14 promoter polymorphism associated with risk of NASH	2002
Dr Matt Warren Professor Chris Day	Chronic pancreatitis: A treatable, common and under-diagnosed problem in patients with aid	2002
Professor Ann Daly Professor Chris Day	CYP2C9 polymorphism and warfarin dose requirements	2002
Professor Ann Daly Julian Leathart Dr Beate Haugk Professor David Jones Professor Alastair Burt et al.	Evidence that alcoholic liver disease is due to immune mechanisms in genetically susceptible drinkers	2002
Professor Chris Day Dr Sushma Saksena Julian Leathart Professor Alastair Burt Emeritus Professor Oliver James et al.	Genetic evidence supporting the two-hit model of NASH pathogenesis	2002
Professor Chris Day Julian Leathart Professor Ann Daly	Genetic evidence that fatty liver is involved in the pathogenesis of advanced alcoholic liver disease	2002
Professor Chris Day	Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease	2002
Professor Chris Day	NASH-Related liver failure: One hit too many?	2002
Professor Chris Day Professor David Jones	Neo-antigen specific T-cell responses are closely associated with the presence of liver disease in heavy drinkers	2002
Professor Chris Day	Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?	2002
Professor Chris Day	Non-alcoholic steatohepatitis (NASH): why biopsy? - Author's reply	2002
Professor Chris Day Dr Sushma Saksena	Non-alcoholic steatohepatitis: Definitions and pathogenesis	2002
Dr Martin Prince Emeritus Professor Oliver James Professor Chris Day Dr Mark Hudson Professor David Jones et al.	Pain as a complication of opiate antagonist therapy in cholestasis: A single centre experience	2002
Professor Chris Day	Pathogenesis of steatohepatitis	2002
Professor Ann Daly Professor Chris Day Dr Peter Donaldson	Polymorphisms in immunoregulatory genes: towards individualised immunosupressive therapy?	2002
Dr Peter Donaldson Professor Chris Day	Predictive Value of Cytokine Polymorphisms for Liver Disease	2002
Professor Chris Day Dr Richard Virden Emeritus Professor Steve Yeaman	Regulation of phosphatidic acid phosphohydrolase 1 by fatty acids	2002
Professor Chris Day	The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway	2002
Professor Chris Day	Transplantation for alcoholic liver disease	2002
Dr Stephen Stewart Julian Leathart Professor Ann Daly Professor Chris Day	Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis	2002
Dr Stephen Stewart Professor Ann Daly Julian Leathart Professor David Jones Professor Chris Day et al.	A polymorphism in CTLA-4 is associated with the presence of anti-CYP2E1 antibody titres in patients with alcoholic liver disease	2001
Dr Stephen Stewart Professor David Jones Professor Chris Day	Alcoholic liver disease: New insights into mechanisms and preventative strategies	2001
Professor Chris Day	Apoptosis and acute alcoholic hepatitis: a novel therapeutic target?	2001
Professor Chris Day	Apoptosis in alcoholic hepatitis: A novel therapeutic target?	2001
Professor Chris Day Julian Leathart Professor Ann Daly Dr Mark Hudson	Association of a 5'-flanking region polymorphism in the interleukin-4 gene with Crohn’s disease in a British population.	2001
Professor Chris Day Julian Leathart Professor Ann Daly Dr Mark Hudson	Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population	2001
Professor Chris Day	Association of the tumour necrosis factor  -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis	2001
Professor Ann Daly Professor Chris Day	Candidate gene case-control association studies: advantages and potential pitfalls	2001
Professor Chris Day	Heavy drinking greatly increases the risk of cirrhosis in patients with HCV hepatitis	2001
Dr Maria Lorite Professor Alastair Burt Professor Chris Day Professor Albert Geerts	Identification of phospholipase D gene products in activated rat hepatic stellate cells - Stimulation by PDGF and nucleotides	2001
Professor Helen Reeves Professor Alastair Burt Professor Chris Day	Integrin receptor expression changes in diseased hepatic stellate cells	2001
Dr Stephen Stewart Professor Chris Day	Liver disorder and the HFE locus	2001
Dr Stephen Stewart Dr Mark Hudson David Talbot Professor Derek Manas Professor Chris Day et al.	Mycophenolate mofetil monotherapy in liver transplantation	2001
Dr Kaushik Agarwal Professor Ann Daly Julian Leathart Dr Mark Hudson Professor Chris Day et al.	Polymorphisms of immunoregulatory genes: A step towards individually tailored immunosuppression?	2001
Professor Chris Day	Prevalence of auto-antibodies against cytochrome in alcoholic liver disease	2001
Dr Maria Lorite Professor Debra Bevitt Professor Chris Day	Regulation of ADAMS family members in hepatic stellate cells by soluble growth factors: Evidence for their role in hepatic fibrogenesis	2001
Dr Alison Sutherland Professor Chris Day Dr Mark Welfare Professor Ann Daly Dr John Mansfield et al.	Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease	2001
Dr Maria Lorite Professor Debra Bevitt Professor Chris Day	The ADAMs: A modular protein family with metalloproteinase and proteoglycan degrading activities expressed by the hepatic stellate cell	2001
Professor Chris Day Professor Ann Daly	The genetic basis for non-alcoholic and alcoholic steatohepatitis.	2001
Professor Chris Day	Clinical diagnostic scale: A useful tool in the evaluation of suspected hepatotoxic adverse drug reactions	2000
Professor Ann Daly Professor Margaret Bassendine Professor Chris Day	Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease	2000
Professor Chris Day Julian Leathart Professor Ann Daly	Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis	2000
Professor Chris Day	Who gets alcoholic liver disease: Nature or nurture?	2000
Emeritus Professor Chris Seal Professor Chris Day	Alcoholism: Effects on Nutritional Status	1999
Professor Chris Day Dr Patrick Kesteven Professor Ann Daly	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications	1999
Professor Chris Day	HFE and alcoholic liver disease - Reply	1999
Professor Loranne Agius Emeritus Professor Steve Yeaman Professor Chris Day	Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase	1999
Emeritus Professor Oliver James Professor Chris Day	Non-alcoholic steatohepatitis [Reply]	1999
Emeritus Professor Oliver James Professor Chris Day	Non-alcoholic steatohepatitis: Another disease of affluence	1999
Professor Chris Day	The natural history of histologically proved drug induced liver disease	1999
Professor David Jones Emerita Professor Julia Newton Professor Ann Daly Professor Chris Day Emeritus Professor Oliver James et al.	Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis	1999
Professor Chris Day Dr Patrick Kesteven Professor Ann Daly	Warfarin dose requirement and CYP2C9 polymorphisms - Reply	1999
Professor Ann Daly Professor Margaret Bassendine Emeritus Professor Oliver James Professor Chris Day	The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: Effect on age of presentation and dependence on alcohol dehydrogenase genotype	1998